Fundraising Fox

Javara

Winston-Salem, US · Founded 2018 · Delaware corporation · 1 known investors

BiotechHealthtechin /javara@javararesearch

Founders & leadership

JB
JENNIFER BYRNEExecutive Officer, Director
JV
JOSEF VON RICKENBACHDirector
BZ
BRETT ZBARDirector
LM
LINDA MCCARTYExecutive Officer
JK
JEFFREY KASHERDirector
TJ
TODD JOHNSONDirector
ET
ERIKA TAURELExecutive Officer
AD
ANDREW DOMESCIKExecutive Officer
CH
CHARLES HAUSERDirector
GR
GERALD ROACHDirector
JV
JOHN VANNExecutive Officer, Director

Investors · 1

FCA Venture PartnersNashville · $500K – $10M

Reported raises · per SEC filings

Form D private placements
▶$6.6MraisedMay 2025 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JENNIFER BYRNEExecutive Officer, Director
  • JOSEF VON RICKENBACHDirector
  • BRETT ZBARDirector
  • LINDA MCCARTYExecutive Officer
  • JEFFREY KASHERDirector
  • TODD JOHNSONDirector
  • ERIKA TAURELExecutive Officer
Offering amount
$10M
Amount sold
$6.6M
First sale
May 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.4MraisedNov 2023 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • THOMAS H. PIKEDirector
  • JEFFREY KASHERDirector
  • BRETT ZBARDirector
  • ERIKA TAURELExecutive Officer
  • JENNIFER BYRNEExecutive Officer, Director
  • JOSEF VON RICKENBACHDirector
  • LINDA MCCARTYExecutive Officer
Offering amount
$9.4M
Amount sold
$9.4M
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30MraisedApr 2022 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • LINDA MCCARTYExecutive Officer
  • BRETT ZBARDirector
  • ANDREW DOMESCIKExecutive Officer
  • THOMAS PIKEDirector
  • JEFFREY KASHERDirector
  • JOSEPH VON RICKENBACHDirector
  • JENNIFER BYRNEExecutive Officer, Director
Offering amount
$47.5M
Amount sold
$30M
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.3MraisedSep 2021 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • CHARLES HAUSERDirector
  • GERALD ROACHDirector
  • JOHN VANNDirector
  • JEFFREY KASHERDirector
  • CHARLES W (TODD) JOHNSONDirector
  • JENNIFER BYRNEExecutive Officer, Director
  • ANDREW DOMESCIKExecutive Officer
  • LINDA MCCARTYExecutive Officer
  • THOMAS PIKEDirector
Offering amount
$7M
Amount sold
$5.3M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.6MraisedAug 2020 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JEFFREY KASHERDirector
  • JOHN VANNDirector
  • ANDREW DOMESCIKExecutive Officer
  • CHARLES HAUSERDirector
  • GERALD ROACHDirector
  • THOMAS PIKEDirector
  • LINDA MCCARTYExecutive Officer
  • JENNIFER BYRNEExecutive Officer, Director
Offering amount
$4.6M
Amount sold
$4.6M
First sale
Aug 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedAug 2019 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • ANDREW DOMESCIKExecutive Officer
  • JENNIFER BYRNEExecutive Officer, Director
  • CHARLES HAUSERDirector
  • JEFFREY KASHERDirector
  • GERALD ROACHDirector
  • JOHN VANNExecutive Officer, Director
Offering amount
$4.7M
Amount sold
$3.8M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.